Modelling the Effects of Mass Drug Administration on the Molecular Epidemiology of Schistosomes by Lamberton, P H L et al.
  
RVC OPEN ACCESS REPOSITORY – COPYRIGHT NOTICE 
 
This is the Accepted Manuscript of the following article: 
Lamberton, PHL and Crellen, T and Cotton, JA and Webster, JP (2015) Modelling the 
Effects of Mass Drug Administration on the Molecular Epidemiology of Schistosomes. 
Advances in Parasitology, 87. 293–327. 
The final version is available online via http://dx.doi.org/10.1016/bs.apar.2014.12.006.     
© 2015. This manuscript version is made available under the CC-BY-NC-ND 4.0 license 
http://creativecommons.org/licenses/by-nc-nd/4.0/. 
The full details of the published version of the article are as follows: 
 
TITLE: Modelling the Effects of Mass Drug Administration on the Molecular Epidemiology of 
Schistosomes 
AUTHORS: Lamberton, PHL and Crellen, T and Cotton, JA and Webster, JP 
JOURNAL TITLE: Advances in Parasitology 
VOLUME/EDITION: 87 
PUBLISHER: Elsevier 
PUBLICATION DATE: 7 February 2015 (online) 
DOI: 10.1016/bs.apar.2014.12.006 
1 
 
Running Title: Mathematical modelling for molecular epidemiology 
 
Modelling the effects of mass drug administration on the molecular epidemiology of schistosomes 
 
Lamberton, P.H.L.1, Crellen, T.1,2, Cotton, J.A.2., & Webster, J.P.1,3* 
 
1. Department of Infectious Disease Epidemiology, School of Public Health, Imperial College Faculty of 
Medicine, St Mary’s Campus, London W2 1PG, UK 
2. Wellcome Trust Sanger Institute, Wellcome Trust Genome Campus, Hinxton, Cambridge. CB10 1SA, 
UK 
3. Department of Pathology and Pathogen Biology, Centre for Emerging, Endemic and Exotic Diseases 
(CEEED), Royal Veterinary College, University of London, AL9 7TA, UK   
 
*corresponding author. (jowebster@rvc.ac.uk). 
 
 
 
 
  
2 
 
Abstract  
As national governments scale up mass drug administration (MDA) programs aimed to combat neglected tropical 
diseases (NTDs), novel selection pressures on these parasites increase. To understand how parasite populations 
are affected by MDA and how to maximise the success of control programmes, it is imperative for 
epidemiological, molecular and mathematical modelling approaches to be combined. Modelling of parasite 
population genetic and genomic structure, particularly of the NTDs, has been limited through the availability of 
only a few molecular markers to date. The landscape of infectious disease research is being dramatically reshaped 
by Next Generation Sequencing (NGS) technologies and our understanding of how repeated selective pressures 
are shaping parasite populations is radically altering. Genomics can provide high resolution data on parasite 
population structure, identifying how loci may contribute to key phenotypes such as virulence and/or drug 
resistance. We discuss the incorporation of genetic and genomic data, focusing on the recently sequenced 
Schistosoma spp., into novel mathematical transmission models to inform our understanding of the impact of 
MDA and other control methods. We summarise what is known to date, the models that exist and how population 
genetics has given us an understanding of the effects of MDA on the parasites. We consider how genetic and 
genomic data have the potential to shape future research, highlighting key areas where data are lacking, and how 
future molecular epidemiology knowledge can aid understanding of transmission dynamics and the effects of 
MDA, ultimately informing public health policy makers of the best interventions for NTDs. 
Key words: mathematical models, molecular epidemiology, genetics, genomics, transmission dynamics, 
population structure, genetic diversity, schistosomiasis 
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Introduction 
Mass drug administration (MDA) is the recommended strategy of the World Health Organization (WHO) to 
control or, in certain cases, eliminate a sub-group of Neglected Tropical Diseases (NTDs) based on the annual 
distribution of inexpensive and/or donated drugs (Lammie et al., 2006, Webster et al., 2014). Through MDA, 
intensive and prolonged selective pressures are, and will be, placed on these parasites, which may have 
implications for the long-term success of campaigns (Webster et al., 2008, Webster et al., 2014). Policies to 
optimise success become crucial as programmes in selected countries shift from morbidity control toward 
elimination as a public health burden (WHO, 2012).  
Mathematical models have the potential to explore a number of epidemiological features of both interest and 
importance in parasite populations (Levin et al., 1997, Levin, 1992, Anderson and May, 1991). Mathematical 
models can provide profound logistical, financial, temporal and biological benefits through, for instance, testing 
potential disease control strategies prior to final design and implementation (Rivers et al., 2014) or to improve 
current control methods (Turner et al., 2014, Luz et al., 2011). However, valuable models require accurate 
parameterisations and a reliable understanding of the disease dynamics under investigation and how these can, 
and do, respond to differential selection pressures. Unfortunately, to date, few strong predictive mathematical 
models exist for the majority of metazoan parasites under MDA pressure. This is linked to a wider neglect in the 
study of helminth biology and genetics (Prugnolle et al., 2005a) in comparison to protozoan and bacterial agents 
such as malaria and tuberculosis (Hotez and Pecoul, 2010). In the case of several of the NTDs, the extent to which 
mathematical models may be developed and influence public-health policy is limited by this absence of biological 
data on parasite population structure and genetic diversity. Substantial progress is occurring particularly with the 
recent establishment of the NTD modelling consortium (NTD_Modelling_Consortium). However, what remains 
to be addressed are the key data that these models require, particularly on the complex transmission dynamics of 
these often multi-host diseases. 
The landscape of infectious disease biology is being radically restructured through the advancement of population 
genetic techniques, the development of Next Generation Sequencing (NGS) and the abundance of bioinformatics 
data generated from whole genome sequencing (WGS) (Luikart et al., 2003, Oleksyk et al., 2010, Vitti et al., 
2013). Through applying NGS technology to parasite population studies, well designed research can reap the 
benefits of sequence data, such as locating regions of the genome under selection (Valentim et al., 2013), and 
understanding levels and directions of gene flow and infections within and between sub-populations (Kao et al., 
2014). Such information will boost our capacity to model and predict the effects of MDA on disease transmission 
dynamics and selection and how best to maximise control success (Kim et al., 2014).  
Within infectious disease epidemiology, bacteriology has been one of the disciplines to benefit earliest from the 
genomic revolution due to the low cost of sequencing smaller bacterial genomes. Recent work on drug resistant 
Mycobacterium tuberculosis, for instance, has used large datasets to identify key targets of selection (Farhat et 
al., 2013, Zhang et al., 2013), to show how antibiotic resistance spreads at different spatial scales (Harris et al., 
2010), and quantifying how often resistant clones spread between animal and human populations (Mather et al., 
2013). Applying WGS to eukaryotic parasitic organism is complicated by the increased size and complexity of 
genomes. Population genomics approaches in protozoans such as Plasmodium falciparum (Cheeseman et al., 
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2012, Takala-Harrison et al., 2013) and Leishmania donovani (Downing et al., 2011), have been driven by the 
need to identify the locus or loci responsible for drug resistance (Bright and Winzeler, 2013). Within parasitology, 
malaria research has paved the way in WGS and NGS (Volkman et al., 2012) since the P. falciparum genome was 
published over a decade ago (Gardner et al., 2002). For example, a major locus responsible for artemisinin 
resistance in P. falciparum (PF3D7_1343700) (Ariey et al., 2014), was identified using WGS of both a laboratory-
induced resistant line and field isolates, and clear-cut examples of natural selection associated with resistance to 
artemisinin combination therapies in Asia have come from analysis of 91 P. falciparum genomes (Cheeseman et 
al., 2012).  
Despite the recent advances in WGS and NGS, the challenges of genomic analyses of metazoan species are, 
however, still great. The S. mansoni genome of 380 megabases (Mb) (Protasio et al., 2012) is over an order of 
magnitude larger than the 23 Mb genome of P. falciparum (Gardner et al., 2002) and one order again than the 4 
Mb genome of M. tuberculosis (Cole et al., 1998). Under the 50 Helminth Genomes Initiative of the Wellcome 
Trust Sanger Institute (WTSI) and other projects elsewhere (Blaxter et al., 2012), further helminth draft genomes 
are becoming available. While sequencing output is increasing, large genomes are fragmented (Parkhill, 2013) 
and stitching these genomes together into complete scaffolds took years (Holroyd and Sanchez-Flores, 2012). 
Nevertheless, changes in sequencing and mapping technologies are gradually making this process easier and more 
rapid (Chin et al., 2013, Dong et al., 2013), and the Schistosoma genome is starting to be used to study 
anthelminthic resistance. For example, WGS facilitated the finding of the locus responsible for oxamniquine 
resistance in Schistosoma mansoni (Smp_089320) by providing an easy means to generate SNPs between parental 
lines in a staged genetic cross (Valentim et al., 2013). 
As genomic data becomes available and costs of WGS reduce, questions on how to maximise the information 
from such data become pertinent. Here we consider what is known today about the interdisciplinary approaches 
of molecular epidemiology and mathematical modelling. We discuss the current and newly developing techniques 
available in population genetics and genomics and how these could and should be incorporated into novel 
mathematical predictive models, primarily using Schistosoma spp. as a case study. Whilst many excellent 
mathematical models already exist on schistosome epidemiology, beyond the scope of this current article, here 
we focus on those incorporating genetics and genomics. We specifically address what information is urgently 
needed to parameterize mathematical models aimed to help us elucidate: i) key questions relating to the basic 
biological and transmission potential of schistosome populations under differing MDA pressures; ii) transmission 
cut-off points under repeated MDA informing on when treatments can be stopped, and/or scaled down without 
population infection recrudescing; iii) the potential gauge of when and if drug resistance will arise and how, where 
and how fast it may spread; iv) the role of non-human zoonotic reservoirs in maintaining transmission under 
differential selective pressures; and v) the potential for novel introgressed hybrid schistosomes to emerge and 
establish. We conclude by highlighting priority areas for future cross-disciplinary research in this emerging area 
and how findings can be translated into policy. 
Schistosomes as a ‘model’ for anthelminthic MDA  
Schistosomes, the causative agent of schistosomiasis, are amongst one of the major NTDs targeted by MDA. 
Schistosoma spp. are indirectly-transmitted dioecious trematode macroparasites, with an asexual stage in an 
5 
 
intermediate host snail and a sexual stage within a definitive mammalian host. Schistosomiasis infects >200 
million people with >750 million at risk, of which over 90% are within sub-Saharan Africa (SSA) (Steinmann et 
al., 2006). Two forms of human schistosomiasis are recognised - urogenital and intestinal. Urogenital 
schistosomiasis, from infection by Schistosoma haematobium, is associated with haematuria, bladder damage and 
a risk of progression to kidney failure and bladder cancer. More than 150,000 people die annually from 
S. haematobium-related kidney failure. Intestinal schistosomiasis is predominantly caused by S. mansoni in SSA 
and S. japonicum in Asian foci, and is associated with bloody diarrhoea, hepato-splenomegaly and liver failure 
(Gryseels et al., 2006). Schistosomiasis is primarily treated and controlled through MDA with praziquantel (PZQ) 
to school-age children in endemic districts. The Schistosomiasis Control Initiative (SCI), based at Imperial 
College London, has been instrumental in providing over 100 million praziquantel (PZQ) treatments across parts 
of SSA from 2003-2014 (Fenwick et al., 2009, Webster et al., 2014). Vast numbers of the drug are donated through 
private-public partnerships including by pharmaceutical companies such as Merck-KGaA who have pledged to 
increase their donations and provide 250 million PZQ tablets annually for SSA by 2016. As treatment efforts are 
stepped-up, stronger selection pressures will be imposed on populations of Schistosoma spp. (Webster et al., 2008, 
Webster et al., 2014).  
The genomes of the three major schistosome species of humans have been published  - S. mansoni (Berriman et 
al., 2009), S. haematobium (Young et al., 2012) and S. japonicum (Schistosoma japonicum Genome and 
Functional Analysis, 2009), and have been made accessible through SchistoDB (Zerlotini et al., 2013).  
Unpublished draft genome data for a further eight Schistosoma spp. are also now available from the Wellcome 
Trust Sanger Institute (http://www.sanger.ac.uk/research/initiatives/globalhealth/research/helminthgenomes/). 
While these data have already been put to use in studies on functional (Protasio et al., 2013, Valentim et al., 2013) 
and comparative genomics (Tsai et al., 2013), work on population genomics is in its relative infancy. 
Microsatellite studies have instead been the mainstay of recent Schistosoma evolutionary analysis, including 
population genetic studies examining potential changes to microsatellite diversity of S. mansoni before and after 
PZQ MDA. A key 2005-6 study in Tanzania (Norton et al., 2010), for instance, revealed a significant reduction 
in the allelic richness of S. mansoni following PZQ, within individuals treated, but most notably at the population 
level, as revealed by a similar reduction in genetic diversity observed in the youngest cohort of previously 
untreated children. Data from Senegal collected in 2007-8 in a similar study used microsatelites to analyse 
miracidia collected from 12 children pre and post treatment/s. The authors, however, found no significant changes 
to allelic richness or expected heterozygosity in S. mansoni before and after two rounds of treatment with PZQ 
amongst this small sample group (Huyse et al., 2013). In addition no reduction in genetic diversity following four 
years of MDA was observed in parasites from children in Western Kenya (Lelo et al., 2014). Likewise a 
microsatellite study in Brazil (Blanton et al., 2011) which compared the similarity of S. mansoni populations that 
survived PZQ treatment with susceptible worms also found no significant difference according to the 
differentiation index (Jost, 2008). Such inconsistencies could be due to differences in sample sizes used or due to 
true biological differences.  Future molecular and mathematical modelling analyses would help elucidate this, by, 
for instance, estimating the minium number of miracidia per individual required and/or the number of individual 
host samples required to provide robust estimates of genetic diversity (French et al., 2012). It should also be 
acknowledged that the number of microsatellites needed to accurately infer an effect, varies greatly with the nature 
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of the question, the scale of the analyses, the specific parameters to be estimated as well as the sample size.  Any 
apparent absence of differentiation or change at neutral markers is not, however, necessarily indicative of whole 
genome processes (Allendorf et al., 2010).  A study on Atlantic cod (Pampoulie et al., 2006), for instance, showed 
that very little genetic differentiation (Fst) was observed over nine microsatellite loci, but that substantial variation 
was taking place at the PanI locus, which is known to be under natural selection. The level of detail that genomics 
can now provide, particularly in terms of  parasite population structure, transmission dynamics, and genetic 
diversity and how these are affected by MDA, as well as the more specific effects of treatment on drug resistance 
and other genetic traits such as virulence, will greatly aid parameterisation of transmission models thereby helping 
policy makers formulate informed decisions on how to maximise control of these NTDs while minimising the risk 
of development and/or spread of drug resistance.  
Micro-evolutionary processes 
Some of the most genetically explicit models for multi-host parasites focus on basic population biology (Prugnolle 
et al., 2005a, Criscione et al., 2005). Analyses of genetic variation in parasites at different hierarchical levels 
enables elucidation of parameters such as gene flow, effective population sizes and breeding units, all information 
relevant for understanding the potential rate of spread of important traits such as drug resistance (Anderson and 
May, 1991).  Schistosomes have, however, several rather unique aspects of their biology, separating them from 
other trematodes.   Prugnolle and colleagues used an infinite island model to explore the alternation of sexual and 
asexual reproduction in monoecious trematodes on the partitioning of genetic variance among and within 
definitive hosts (Prugnolle et al., 2005a). Variation in reproductive success of clones was found to be important 
in shaping the distribution of the genetic variability both within and among definitive hosts (Prugnolle et al., 
2005a, Prugnolle et al., 2005b) and Fis (a measure of inbreeding) increased with higher levels of self-fertilisation 
(Prugnolle et al., 2005a), limiting the scope for gene flow within these populations. Schistosomes are believed t 
have no or low levels of inbreeding (Basch and Basch, 1984, Prugnolle et al., 2005c, Huyse et al., 2009), and 
hence it might be predicted that Fis values would be lower for these organisms than for monoecious trematodes, 
with future models fitted to field molecular data helping to elucidate this. 
The same group parameterised a model for dioecious trematodes, and compared their theoretical findings with 
empirical S. mansoni data from Guadeloupe (Prugnolle et al., 2005b). These models examined differential life-
history traits such as sex biased dispersal or clonal reproductive success (Prugnolle et al., 2002). Such 
characterizing of host and parasite population genetic structure and estimating gene flow among populations is 
essential for understanding co-evolutionary interactions between hosts and parasites (Prugnolle et al., 2005c). 
Their models, however, assume non-overlapping generations. Adult schistosomes can live for, on average 6-15 
and up to 40 years within a human host, and as hosts are repeatedly exposed over their lifetime, generations of the 
adult schistosome populations can and do overlap. It is unknown what the effects of overlapping generations are 
with regards to population structure among hosts and if overlapping generations might impact the genetic effects 
of drug treatment. Inclusion of over-lapping generations in mathematical models would undoubtedly increase the 
mathematical complexity (Prugnolle et al., 2005a), but may be in many cases the most biologically realistic 
scenario. In addition it is known that schistosome males can competitively mate (Tchuem Tchuenté et al., 1995, 
Tchuem Tchuenté et al., 1996, Webster et al., 2007) and therefore a male which survived treatment could mate 
with a surviving female, and/or including any female protected from the drug by a dying male within one 
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generation.  New males from subsequent generations could also competitively mate with females from earlier 
generations, leading to pairs from these overlapping generations. Such competition among males will lead to an 
increased variance in male reproductive success. This could pleasible be higher with drug treatment, in comparison 
to natural death and generation turnover, as the new cohorts of males infecting the hosts post treatment may be 
fitter than those which have been exposed to the drugs, but could mate with previously exposed, but surviving 
females. The inclusion of overlapping generations in mathematical model design could thus have profound 
implications on the predicted spread of drug resistance via sexual reproduction. Work by Xu et al (2006) has 
indeed demonstrated the importance of incorporating mating structure into model design, where he showed the 
potential maintenance of drug-resistant strains of schistosomes where generations overlap in comparison to 
simpler models without mating structure.  Furthermore, such mating structure models suggested that multiple 
strains of drug-resistant parasites are likely to be favoured as the treatment rate increases (Xu et al., 2006). Models 
produced to date have also suggested that the likelihood that these resistant strains will increase in frequency also 
depends on the interplay between their relative fitness, the costs of resistance, and the degree of selection pressure 
by the drug treatments (Feng et al., 2001).  
Macro-evolutionary processes 
Molecular models for macro-epidemiological processes directly relevant to public health policy makers are scarce, 
despite the fact that population genetics and epidemiology both extend basic biological processes at the individual 
level to the population level, and clearly come together to model drug resistance (Levin et al., 1997). The 
difference in the spread of drug resistant genes through a parasite population to that of drug resistant parasites 
through a host population, is that drug resistant alleles replace sensitive alleles depending on their relative fitness, 
whilst drug resistant parasite densities increase according to their absolute fitness (Paterson and Viney, 2000). 
This difference is of greater importance in complex parasite systems where high levels of genetic diversity are 
required to complete the life-cycle, such as schistosomes (Rollinson et al., 2009), with stronger constraining 
selective pressures acting on the parasites at different life-cycle stages than, for example, directly transmitted viral 
pathogens. Because the rate of increase of a parasite population (and therefore the density of the parasite 
population) depends on R0, the epidemiology of anthelmintic resistance cannot be determined without using a 
model which incorporates the underlying genetics of resistance (Paterson and Viney, 2000). Smith and colleagues 
used estimates of the absolute fitness of different parasite genotypes within an epidemiological framework to 
model the effects of under dosing, treatment strategies and mating probabilities on anthelmintic resistance (Smith 
et al., 1999). Such a model demonstrates how population genetics can help build theoretical models of infectious 
disease to understand patterns of transmission in the field. 
 
The role of genetics and genomics in mathematical models in order to: 
Elucidate the basic biology and transmission potential of schistosomes 
Population structure 
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In many countries the majority of MDAs, particularly for schistosomiasis and soil-transmitted helminths (STH), 
target school-aged children. The effects that such treatment strategies have on parasite transmission dynamics, as 
well as the potential selection pressures, depend on a range of factors. These include at least three directly relating 
to refugia (the proportion of the parasite population not exposed to the drug): 1) the proportion of school-aged 
children who attend school and therefore receive treatment, 2) the proportion of the population that are school-
aged, and 3) the proportion of the total parasite population harboured by this targeted treatment group. Additional 
key factors include drug efficacy, life-history costs/trade-offs of resistance, and parasite population diversity, 
structure and transmission dynamics, such as how different age groups are exposed to eggs or infective larvae 
produced by these school-aged children and vice versa (Anderson et al., 2013). These factors affect on-going 
transmission and re-infection of treated, and untreated, individuals as well as influencing the potential 
development, rate, and spread, of drug-resistant strains. 
Models can aid understanding about potential benefits that school-based MDA may have on untreated groups. For 
example, if parasite population structure, elucidated through genetics and/or genomics, indicates that children and 
adults were found to be infected from a similar genetic pool of parasites (i.e. no genetic differentiation of parasites 
between children and adults), then treating children may potentially decrease infection in the untreated adult 
communities, recently termed the ‘herd impact’ of a treatment programme (Anderson et al., 2013). Conversely, if 
parasites in children only tend to circulate within their age groups, then infection intensities in adults will be 
unaffected by only treating the children.  
Although measuring transmission rates in multi-host systems is difficult, data on genetic variation within an 
individual and population level hierarchy can also enable measurements of genetic structure and associated rates 
of gene flow (Weir and Cockerham, 1984). Genomic and gene flow data can likewise be used to build transmission 
trees, including those aimed to identify, for certain microparasites at least, the origins of any new infections (Kao 
et al., 2014). While these approaches may have lower resolution in metazoan parasites, due to their slower rates 
of molecular evolution, multi-locus and genomic approaches will allow us to approximate intraspecific 
phylogenies and elucidate transmission between hosts, as has been demonstrated for Ascaris (Criscione et al., 
2010). Such data become vitally important as control programmes move towards elimination, highlighting key 
individuals or sub-populations driving re/infections. Examples of where genetic data has already informed public 
health policy include a study on Ascaris in pigs and humans in Guatemala, where even though infections were 
sympatric, there appeared to be, using the molecular tools available at the time, little gene flow between the 
parasite populations indicating no transmission between the two host species (Anderson et al., 1993). Conversely 
two other more recent studies have indicated cross transmission between the Ascaris lumbricoides and A. suum 
species, with, furthermore, up to 4% and 7% of Ascaris appearing as hybrids, which raises a number of potential 
implications for long-term evolutionary dynamics (Criscione et al., 2007).  Models have already been used in 
directly transmitted pathogens, including sexually transmitted diseases, where contact tracing data may not be 
complete, but where genome data can inform on infection networks (e.g. HIV transmission in a dental practise 
(Ou et al., 1992) as well as theoretical pathogen models using evolutionary trees resulting from different 
evolutionary processes (Nee et al., 1994). In microparasites with rapid in-host evolution sensitivity of 
phylogenetic based networks may be reduced (Resik et al., 2007). Similar lack of contact tracing exists for 
indirectly transmitted pathogens such as STHs and schistosomes and microparasite models incorporating similar 
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genomic data may be developed for more complex indirect transmission networks (Gupta et al., 1996) and may 
be highly dependent on host immunological factors (Anderson et al., 1989). 
At present mathematical models of indirectly transmitted parasites often assume that exposure to eggs or larvae 
across all age groups is random and independent of the relative contribution of infective stages from each age 
group and maintained transmission. However, the spatial structure of concomitant parasite transmission between 
age groups is unlikely to be random and even less so with MDA programmes targeting specific groups of 
individuals. Therefore, models should incorporate such heterogeneous mixing (Chan et al., 1994). An additional 
complication is that transmission dynamics and population biology are likely to change if MDA reduces parasite 
transmission significantly (Klepac et al., 2013). In addition, models for such organisms, with the exception of 
(Gurarie and King, 2005), also assume that hosts sample from a common source of infection.  However, even on 
a very local scale, parasites have been shown, using population genetics, to have focal transmission (Criscione et 
al., 2010) independent of the among age-group population structures, negating some of the classic models for 
parasite transmission. 
Above, we have discussed how population genetics can inform on specific treatment scenarios, and be used to 
predict gene flow between certain individual hosts, or host groups. On a larger and more basic scale, population 
genetics can inform on the very basis of what types of models should be used for certain diseases. At present some 
network contact models estimate transmission patterns purely from host behaviour. The use of population genetics 
and genomics enables elucidation of contact network structures, even at the most basic level. Questions such as 
whether transmission is random or non-random, and therefore which model is appropriate to fit the data, can be 
answered, as has already been initiated as for A. lumbricoides in Nepal (Criscione et al., 2010). This is particularly 
important for multi-host parasites where several transmission mechanisms could result in a similar profile. To 
date, many of the theoretical challenges faced by epidemiologists and population geneticists were problems of 
scale, whilst the use of population genomics greatly diminishes these challenges.  
Transmission Rates 
Changes in the transmission rate of macroparasites may be inferred from longitudinal changes in descriptive 
statistics (prevalence, infection intensity), or modelled through the force-of-infection (FOI: the rate at which 
human hosts acquire parasites). Uganda, for instance, has been treating individuals with PZQ since 2003 with 
significant reductions in prevalence, infection intensity and FOI after only three rounds of MDA in low, moderate 
and high infection areas in both treated and untreated children (French et al., 2010). However, Basáñez and 
colleagues argue that presently there are very few models with the potential to inform on optimal methods at a 
clinical or epidemiological level to monitor such changes and they outline a number of areas for future model 
development. These include “the design of treatment efficacy and effectiveness studies; phenotypic 
characterisation of responses to treatment; and design of sampling protocols for the study of parasite genetic 
structure under treatment, thereby facilitating prompt detection of anthelmintic resistance” (Basáñez et al., 2012). 
Examples of modelling work already carried out in this field include studies examining the effect of density-
dependent forces known to act on parasites generally, including schistosomes (Medley and Anderson, 1985) and 
the effect of human and parasite sample sizes on measuring reductions in genetic diversity in S. mansoni infections 
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post treatment (French et al., 2012). Both of these factors are vitally important, particularly as control programmes 
progress and infection intensities reduce. 
Genomic techniques can be employed to gain a better understanding of the nature of transmission in endemic 
settings, including those under differing MDA pressures (Volkman et al., 2012). Within a parasite population, the 
degree of outbreeding and recombination is linked to the proportion of people harbouring parasites of variable 
genotypes; this proportion is known to scale with the level of transmission (Anderson et al., 2000). A study on the 
Thai-Burma border where transmission of P. falciparum has declined from 2000-2010 associated a loss of 
heterozygosity across 96 SNPs with the sampling year (Nkhoma et al., 2013) using logistic regression, therefore 
multiple genotype infections had significantly declined over time in line with falling transmission. A study in 
Senegal found a similar reduction in the heterozygosity of P. falciparum populations as a consequence of public 
health interventions (Daniels et al., 2013). Nkhoma and colleagues argue that the linear relationship between the 
carriage of multiple parasite genotypes within human hosts and transmission intensity means that population 
genetics can be used as a reliable and inexpensive method of tracking temporal changes in transmission intensity 
(Nkhoma et al., 2013). Despite very different lifecycles, the effects seen in P. falciparum are likely to be replicated 
in Schistosoma spp. In both parasites, the total populations are subdivided within each definitive host (Anopheles 
in the case of P. falciparum and humans in the case of Schistosoma spp.), meaning that sexual reproduction for 
any individual parasite is possible only with a small fraction of organisms from the total population. This presents 
barriers to gene flow and outbreeding and so the reductions in heterozygosity are enhanced in both species. It may 
be expected to occur more slowly in schistosomes, due to a longer generation time, the relatively higher intensities 
of infections in humans than in the mosquitoes, and the different timing of sexual reproduction in the two 
lifecycles.  
 
Spatial heterogeneity 
Modelling spatial and demographic heterogeneity with the aim of understanding fundamental processes 
underlying infection dynamics provides a framework for evaluating potential control strategies for infectious 
diseases (Paterson and Viney, 2000). Using well-documented and commonly modelled systems, such as measles, 
social and geographical structure in contact networks have been deduced with heterogeneity in transmission rates 
within families, between children at school and between communities (Keeling et al., 1997). Models for 
macroparasites may also highlight key social and geographical groups where transmission is high. However, in 
indirect life-cycles, this is hard to do from host behaviour and contact monitoring. Parasite population genetics 
and genomics can ultimately inform on transmission structure. Heterogeneity in infection patterns are biological 
realities and must be incorporated into models (Paterson and Viney, 2000) improving their fit to empirical data. 
Kao et al (2014) review the use of WGS in contact tracing models to reveal points of control and predict directions 
of spread of diseases for microparasites (Kao et al., 2014). They discuss the complexities associated with inferring 
the epidemiological dynamics of multi-host pathogens, as is often the case for NTDs. Furthermore these authors 
explore the difficulties of when microparasite mutation rates are low in comparison to generation times, but that 
such situations may be resolved using within-host genetic variation to infer properties of between-host 
transmission (Stack et al., 2013). While these methods may be less powerful in metazoan parasites, whole-genome 
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data will certainly reveal significant details of the spatial genetic structure for these organisms (Archie et al., 
2009). 
 
Evaluate transmission cut off points and estimating when to stop MDA 
Population genetic mathematical models can also inform on cut-off points for MDA through predicting the levels 
of infection where disease transmission should not recrudesce (Plaisier et al., 1997, Turner et al., 2013). This has 
been demonstrated for the NTD trachoma (Chlamydia trachomatis) in communities where MDA of antibiotic eye 
ointment are used (Lietman et al., 2011). This model included estimates of transmission parameters relating to 
reinfection from both within or outside the community. The values were robustly estimated from prevalence data 
at baseline and 24 month follow up.  Nevertheless, future additional data on the level of gene flow over time and 
space and phylogenies of the infections appearing following treatment would enable control programmes to know 
the true influence of recrudescence and reinfection from within or outside the community. Such data would also 
inform on the distance that re-infection can occur from aiding policy makers in their decisions on when they can 
halt treatment in a central focus, depending on threshold infection levels in a range of surrounding foci. Population 
genomic data could also parameterise smaller spatial household models, identifying the extent of gene flow within 
and between infected sub-populations (Blake et al., 2009). Similar transmission potential parameters could be 
incorporated into other vector-borne/intermediate host disease elimination models, such as for S. haematobium on 
Zanzibar for example, where they are aiming toward elimination (Rollinson et al., 2013).  Of particular value 
would be the use of genetic and genomic data to understand if any detected cases remaining or reappearing were 
from local transmission or imported cases from the mainland.   Such genomic data has already enabled 
reconstruction of transmission trees for directly transmitted non NTDs, for example, understanding cross-species 
transmission in Salmonella (Mather et al., 2013). 
Parasite diversity may also strongly affect transmission dynamics, reinfection rates post treatment and associated 
thresholds for ending MDA. Strain diversity in trachoma, for instance, is known to affect reinfection levels, as 
heterogeneity exists in part to evade the human immune system. If many strains become eliminated, then the 
remaining ones may not be able to reach pre-treatment levels due to independent factors such as strain specific 
host immunity (Zhang et al., 2004). Incorporating diversity into models predicting MDA cut off points, may 
thereby not only greatly enhance their accuracy, but also aid in the understanding of such interventions on the 
transmission dyncmais of the infectious agent, as has recently demonstrated for dengue (Coudeville and Garnett, 
2012).  
 
Elucidate the potential evolution and spread of praziquantel resistance 
 
Early detection of anthelminthic resistance is vital for controlling the spread of such genotypes. When (Churcher 
and Basáñez, 2009) and how (French et al., 2012) best to examine human helminth parasite populations post 
treatment, have recently been the subject of model-based studies. If PZQ resistance is recessive, drug resistant 
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alleles could spread through the population to relatively high levels before phenotypic manifestation (Churcher 
and Basáñez, 2009). There is also evidence for negative density-dependent fecundity in S. mansoni (Medley and 
Anderson, 1985) and models on helminth life-cycles show that density-dependent fecundity, in comparison to that 
in parasite establishment or mortality (Churcher and Basáñez, 2008) may facilitate the spread of resistance as 
parasite population intensities decrease with treatment. One of the most important aspects of mathematical models 
is their direct use to public health policy makers. A recent model based on antibiotic resistance and drug use and 
how to communicate the extent of problems to policy makers (Laxminarayan and Klugman, 2011) could be 
adapted for other infections to maximise the speed of implanting changes in control strategies should they be 
required. 
Some modelling work to date has taken into account the life-cycle of schistosomiasis by using a time-delay 
function and found that the presence of this delay, i.e. the average time between two adult generations, makes it 
more likely for resistant strains, for example, to invade and persist in a parasite population (Castillo-Chavez et al., 
2008). Furthermore, population genetic analysis of the structure of S. mansoni and S. haematobium diversity 
across Africa using microsatellite markers, found that, on the basis of population structuring and high genetic 
diversity, should drug resistance evolve it would be slow to spread through schistosome populations, at least 
across large scales (Gower et al., 2013), as there were low levels of gene flow observed between samples from 
different countries (although high levels of gene flow between samples within countries). As with many parasite 
species, the complex nature of the schistosome life-cycle violates assumptions of the Wright-Fisher (WF) model: 
with highly overlapping generations due to the long reproductive lifespan of adult schistosomes and non-random 
mating due to focal transmission and inability to mate with schistosomes in other hosts. These effects make it 
difficult to make use of genetic variation at neutral sites to understand population size and structure (Balloux and 
Lehmann, 2012) and to predict how effective natural selection will be in increasing the frequency of positively 
selected alleles in the face of random drift or constraining selective pressures elsewhere in the complex life-cycle. 
A population genetic model recently developed for malaria, which aids understanding of the emergence of 
resistance and its early spread (Kim et al., 2014), in this instance under combination drug therapy (something 
which is not currently available for schistosome treatment), will likely act as a key foundation for other indirectly 
transmitted parasite genetic models in the near future. 
Recent mathematical models on large-scale PZQ administration have shown that the FOI of S. mansoni is reduced 
throughout communities; even in untreated PZQ naïve individuals, as control programmes progress (French et al., 
2010). Such a FOI however is calculated from humans, through snails and back into humans, with little knowledge 
on the relative force between individual life-cycle stages. In S. japonicum, an Asian species which has multiple 
definitive hosts, the driving FOI is the transmission from snail to mammal (Riley et al., 2008), with different 
mammalian hosts maintaining transmission in different geographical regions (Lu et al., 2010, Rudge et al., 2013). 
In an S. mansoni focus in Guadeloupe, similar molecular epidemiology studies have indicated that parasite 
migration is primarily driven by the rodent hosts (Prugnolle et al., 2005c). Little however is known about the 
relative forces and spatial heterogeneities in S. mansoni and S. haematobium between sub-populations of parasites 
in humans or on the effect of PZQ. Future work needs to expand current FOI models, to include drug resistant 
parameters, and determine the driving forces of continued transmission despite repeated drug treatments. As 
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schistosome control programmes progress, empirical and theoretical data warrant further research on PZQ 
efficacy, and how best to monitor and evaluate (M&E) disease transmission, to maximise the life span of PZQ.  
As some countries or regions in countries push towards elimination (Rollinson et al., 2013), bi-annual treatment 
with PZQ has been a suggested strategy to further reduce the FOI and halt transmission.  One key area that 
mathematical models should evaluate is the effect of bi-annual MDA on the potential increased selection for 
resistance, versus the rate of reducing the FOI (French et al., 2010).  Models should be fitted to known clearance 
data post treatment to elucidate the relative contribution of non-clearance versus reinfection in maintaining high 
infection intensities. These models should then incorporate the currently unknown parameters for PZQ-resistance, 
starting with a simple single locus model and progressing to multilocus genotypes. This would inform policy 
makers on the potential risks of increasing treatment frequencies, versus the potential benefits of reducing FOI, 
for a range of scenarios for potential genotypic resistance to the drug. 
In the absence of any current molecular markers for monitoring potential PZQ resistance, or even a full 
understanding of the molecular mechanisms of PZQ action (Chan et al., 2013), phenotypic tests have been trialled 
with some success in both the laboratory and the field (Liang et al., 2001, Lamberton et al., 2010). Accurate 
phenotypic measures of drug efficacy are a vital requirement for comparison of genomic sequences to locate 
potential genes and/or regions associated with drug resistance. Complexities arise with several chronic 
macroparasite infections as methods for phenotypically detecting resistance are often not properly standardised. 
In schistosomes, the WHO designated phenotype for drug tolerance is lowered ‘cure rates’ and/or ‘egg reduction 
rates’ as measured by Kato-Katz thick smears (Katz et al., 1972) or urine filtration, depending on the species,  
before and 14-21 days following treatment (WHO 2013). Limitations in the sensitivity of such diagnostic tests 
(Lamberton et al., 2014) may restrict the inferences that can be drawn from any association testing between 
polymorphisms and reduced treatment efficacy. An important role for modelling will be to account for the 
limitations in diagnostic accuracy, which is increasingly performed through latent class analysis (Koukounari et 
al., 2013, Assefa et al., 2014). The most recent WHO manual for evaluating anthelmintic drug efficacy 
“tentatively” places the egg reduction rate at approximately 90% for the three main Schistosoma species infecting 
humans when individuals are treated with 40 mg/kg of PZQ (WHO 2013). On the basis of these criteria, treatment 
failures with PZQ, although rare, have been reported (Greenberg, 2013) with systematic non-clearers often 
observed in the field. Warning also comes from veterinary parasitology with anthelminthic resistance an inevitable 
consequence of mass anthelminthic treatment, with parasites in some regions being resistant to all major drug 
classes, leading to total anthelminthic failure (Kaplan and Vidyashankar, 2012, Webster et al., 2014), and 
threatening the profitability of whole sheep farming industries in Australia (Wolstenholme et al., 2004).  
Care must, however, be taken in using genetic data from populations of larval, or egg, stages as a proxy for adult 
worm intensity or reproduction (Criscione and Blouin, 2005), or to measure transmission between hosts (Steinauer 
et al., 2010, Steinauer et al., 2013). Population genetics and/or genomics have been used to overcome these 
problems estimating the adult population sizes through kinship analysis to either partition miracidia into sibships 
or assign miracidia to parents of the parasites under investigation (Blouin, 2003, Jones and Ardren, 2003, 
Criscione and Blouin, 2005, Steinauer et al., 2013). This has also enabled the accurate incorporation of density-
dependent factors into models by drawing comparisons between adult population sizes and egg counts at the 
individual level. Ne is an important parameter in evolutionary biology because it quantifies genetic drift, and 
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crucially with regard to MDA and potential drug resistance, the response to selection (Criscione and Blouin, 
2005). Ne has a large influence on the overall level of genetic diversity in populations and selection for drug-
resistance alleles might be more efficient in parasite populations with a large Ne. The complex life-cycles of many 
NTDs affect the type of model chosen to estimate the effective population size (Ne) (Balloux and Lehmann, 2012) 
and make it more challenging to collect samples from appropriate life-cycle stages to infer genetic estimates, and 
to collect the necessary demographic data, such as generation time, that may be needed to augment these genetic 
estimates. For example, in many NTDs, such as schistosomes, the eggs from sexual reproduction are passed into 
the external environment, so that offspring from different infrapopulations are mixed every generation. Criscione 
and Blouin use a model which subdivides breeders into infrapopulations, nested within a component population, 
to demonstrate basic demographic factors that control Ne in macroparasite species (Criscione and Blouin, 2005). 
They incorporate incomplete mixing, which increases reproductive success of some infrapopulations and discuss 
the effects of aggregation and crowding on per capita fecundity, both aspects vitally important in future models 
on the potential rate of spread of drug resistance. They also demonstrate a pronounced sex-ratio effect on Ne due 
to separation of individuals among hosts. Such a model would be greatly enhanced by knowledge gained from 
kinship analysis through population genetics or genomics, briefly mentioned above (Blouin, 2003, Jones and 
Ardren, 2003), which would inform on reproductive success and density-dependent factors enabling the accurate 
estimation on the effective number of breeders in each infrapopulation, which could then be incorporated into 
models and would be even more important after MDA when density-dependent pressures may be reduced on 
potentially resistant strains. 
Apart from details of the population structure and reproductive biology of the parasite population, the speed and 
extent of spread of drug-resistance alleles will depend on the detailed genetic architecture of drug resistance. 
Factors include how many loci are involved, how loci interact in determining resistance phenotypes, whether and 
to what extent the loci are genetically linked and whether resistant alleles are dominant, recessive or something 
in-between, the relative fitness of resistant genotypes in the presence of drug treatment, the cost of resistance 
(reduced fitness in the absence of drug treatment), and the degree of selection pressure exerted by treatment on 
different populations. Basáñez et al (2012) discuss models capturing some or all of these factors for some parasite 
species, including a number of schistosome-specific models, but nothing is known about loci underlying clinical 
failure of PZQ treatment or PZQ resistance, let alone any information to parameterise the other factors required 
for accurate, model-based prediction of the potential for drug resistance. 
Using population genomics to understanding the mode of PZQ resistance 
Circumstantial evidence suggests that PZQ acts on voltage-gated Ca2+ channels (Doenhoff et al., 2008, Chan et 
al., 2013). While these insights are important, whole-genome approaches enable an unbiased approach to 
understanding the genetics of drug resistance, avoiding potential biases from prior assumptions about mechanisms 
of action and/or resistance embodied in the choice of ‘candidate genes’ for more targeted genotyping approaches. 
Traditional ‘forward’ genetics approaches based on analysis of a genetic cross are possible in Schistosoma 
(Criscione et al., 2009) and have been successfully applied to understanding the genetics of drug resistance to 
Oxamniquine in one isolate (Valentim et al., 2013). Reverse genetic approaches such as transgenesis and RNAi 
are also available, or under active development for Schistosoma, and while not yet sufficiently reliable for high-
throughput for ‘discovery’ of loci underlying resistance phenotypes, such techniques may be valuable in 
15 
 
confirming the importance of candidate loci discovered by other approaches. More fundamentally, these kinds of 
laboratory genetics approaches allow detailed investigation of causal loci in individual resistant isolates, but unless 
diverse isolates can be looked at – and relatively few schistosomes isolates are now maintained in laboratories, 
and once introduced from the field rapid genetic bottlenecks occur (Gower et al., 2007) – these loci may not be 
responsible for resistance observed in clinical conditions.  
A complementary approach is to investigate genetic variation in natural populations. A conceptually simple 
approach is to look directly for genetic variation that is associated with a quantifiable phenotype, such as drug 
resistance (Borrmann et al., 2013, Takala-Harrison et al., 2013, Zhang et al., 2013). The key difficulties for using 
such approaches in schistosomes at present lie in the lack of a diagnostic test for reduced PZQ efficacy, in part 
due to the complexity of the parasite genome and life-cycle and likely polygenic basis for such resistance. An 
alternative is to look for the impact of selection caused by drug treatment using genome-wide sequence data, an 
approach that implicitly assumes that chemotherapy is one of the most important selective forces on these 
genomes.  Methods to detect recent selection are looking for the signals of a selective sweep (Smith and Haigh, 
1974), in which a polymorphism under selection increases in frequency rapidly in a population, and the speed of 
this spread is sufficiently fast that an extended contiguous portion of a chromosome will spread through the 
population alongside the variant under selection, as there has not been enough time for this unit (haplotype) to be 
broken up through recombination. Different tests look for different patterns in the distribution of genetic variation 
across the genome and within populations generated by this process – these tests have been reviewed a number of 
times recently (Volkman et al., 2012, Oleksyk et al., 2010, Vitti et al., 2013). Examples of the patterns are 
enhanced linkage disequilibrium (LD) and depleted polymorphisms around a region, using tests such as the long-
range haplotype test, which in malaria for example have detected drug-resistant loci for chloroquine (Wootton et 
al., 2002) and pyrimiethamine (Nair et al., 2003), or differences in allele frequencies in populations under selection 
and those without selection. More sophisticated statistical tests build on these approaches e.g. XP-EHH (Sabeti et 
al., 2007, Grossman et al., 2010). These tests are often performed from in vitro cultures for drug resistance 
markers, with linkage mapping using laboratory crosses to correlate segregation patterns in the progeny that are 
associated with the drug resistant phenotype (Ferdig et al., 2004, Hayton and Su, 2008, Sanchez et al., 2011).  
Knowledge on the effect of MDA on parasite genotypes, such as virulence and drug resistance, and their potential 
costs, are required to understand the risk of development and then spread. Understanding gene flow between sub-
populations also informs on levels of refugia as touched upon previously, which is a key strategy for minimising 
the risk of drug resistance developing. It is imperative that we understand the complex interactions between 
minimising selective pressures, but treating the most heavily infected individuals, whilst maintaining an optimum 
level of refugia to maximise the short and long-term control of these NTDs. 
Models developed for the demographics of human and malaria movement (Pindolia et al., 2013) and the potential 
spread of drug resistant malaria (Anderson, 2009, Lynch and Roper, 2011) indicate the type of predictive maps 
that can be produced for indirectly transmitted pathogens on regional (Pearce et al., 2009), national (Pindolia et 
al., 2013) and international (Lynch and Roper, 2011) scales. Given the often transitory migration lifestyles of 
many fishermen and their families in areas of high Schistosoma spp. endemicity, monitoring human movement, 
potentially through national migration statistics could be extrapolated to these metazoan parasite species. 
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Elucidate the potential role of non-human definitive hosts 
Zoonotic reservoirs affect the transmission dynamics of a disease and can limit the extent to which a pathogen 
can be controlled or potentially eliminated (Taylor et al., 2001). Work on the zoonotic S. japonicum offers an 
example of how inter-disciplinary research with population genetics and modelling can be done successfully. 
Schistosoma japonicum is unique among schistosome species in that it can infect over 40 mammalian hosts and 
with zoonotic transmission an important factor in its epidemiology (He et al., 2001). Despite a concerted public 
health effort over many decades, the Chinese government has been unable to eradicate S. japonicum (Wang et al., 
2008). Population genetic analyses found close phylogenetic relationships between strains of S. japonicum in 
human and rodent hosts in hilly parts of Anhui Province, China using microsatellite markers, whilst schistosomes 
in the humans in the marshland areas were more closely related to those in bovines, which appear to drive 
reinfection in those areas (Rudge et al., 2009). Bovines were generally assumed to be the primary reservoir of 
human infection (McManus et al., 2010), but population genetic analyses greatly increased our understanding of 
these complex interactions in zoonotic parasites. Knowledge of the genetic similarity and transmission potential 
between hosts was then used to develop a multi-host model of transmission for S. japonicum (Rudge et al., 2013). 
This showed that rodents were the only hosts with a basic reproductive number (R0) > 1 in hilly regions of Anhui, 
China driving transmission and reinfection in treated humans. This explained the re-emergence of S. japonicum 
infection in some mountainous areas of China where the disease was thought to have been eliminated. In 
marshland areas, where bovines R0>1, an earlier government organised cull of cattle may have aided transmission 
control, but similar extreme methods would not have helped in the hilly regions. Rudge and colleagues used a 
prevalence model framework which predicted that a reduction in rodent density by around 20% would lead to a 
40-50% reduction in S. japonicum incidence in humans. This integration of techniques helps inform public health 
policy makers on how best to maximise control, through giving fixed targets which need to be reached to bring 
the overall R0 below 1 and to halt the re-emergence of the disease. Without such population genetic analyses of 
the parasite strains circulating in these regions, the source of human reinfection after these mass treatment 
campaigns would have remained misunderstood, dramatically reducing the cost benefit of specific control 
methods in these regions. Conversely, controlling infections in these host species may potentially induce atypical 
‘refugia’ populations, such as wild animal reservoirs to become more epidemiologically important (Bockarie et 
al., 2013, Webster et al., 2014). 
 
Elucidating the potential role of hybridisation and introgression 
Hybridisation events can have important evolutionary outcomes on species and populations and may improve the 
fitness of resulting hybrids though the acquisition of adaptive traits. Schistosomatoidae are capable of trans-
species mating within the definitive host. Schistosomes are known to hybridize frequently (Steinauer et al., 2010), 
and reports from Senegal have identified hybridisation between S. haematobium/ S. mansoni (Huyse et al., 2013), 
S. haematobium /S. curassoni and S. haematobium / S. bovis (Webster et al., 2013) and between S. mansoni / 
S. rodhaini in western Kenya (Steinauer et al., 2008). The implications of these events for MDA programs have 
yet to be established, but hybridisation may have implications for disease morbidity and drug tolerance and 
therefore represent a public health concern.  
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Continued high transmission of S. haematobium despite often high MDA coverage have recently been molecularly 
identified as being due to, at least in part hybrid infections with S. bovis (Huyse et al., 2009, Webster et al., 2013). 
Since these relatively new PZQ selective pressures have been imposed, any endemic equilibriums of co-infections 
and hybrids may now be changing. Whether or not these hybrids will maintain transmission and/or evolve into a 
potentially drug-resistant parasite species remains to be elucidated, however mathematical models for S. 
haematobium and S. mattheei indicate that such evolution is highly unlikely (Kruger, 1990), although this was 
prior to the introduction of MDA and did not take these extra selective pressures into account. Successful 
modelling work in the future will require both a better knowledge of the transmission dynamics of schistosomes 
under MDA pressure, taking into account factors such as hybridisation and zoonotic hosts, along with a better 
understanding of the genetic loci under positive selection for PZQ resistance.  
Although not based on parasitic life-cycles, models on the origin of species by sympatric speciation (Dieckmann 
and Doebeli, 1999), with explicit description of genetic determinism, may act as starting points for the 
development of models which incorporate hybridization and/or drug resistant alleles.  Dieckmann and Doebeli 
(1999) show that sympatric speciation is a likely outcome of competition for resources, where individuals mate 
preferentially with like individuals, a situation exacerbated in infections where parasites surviving treatment are 
more likely to mate with others also surviving either due to  potentially harbouring resistant alleles, or increase 
resistance through hybrid vigour. Such scenarios could theoretically lead to increased drug resistance despite co-
infections with susceptible parasites, and may ultimately lead to isolation of drug resistant strains within 
individuals harbouring only those parasites which survive treatment. 
Research into adaptive evolution may also act as a useful springboard for future models discussed here. Models 
on plant parasites, for instance, have indicated that evolutionary divergence of parasite phenotypes can be driven 
by seasonal transmission and  associated fitness trade-offs (Hamelin et al., 2011), such as may also occur with 
annual treatments and reduced density-dependent factors. One such recent model describes how competition 
explains intra-host diversification of parasites (Rascalou and Gourbiere, 2014). They show that parasite adaptive 
evolution is faster in highly fragments parasites populations and for weakly aggregated and virulent parasites, all 
factors which could be affected by drug selective pressures, hybridizations and associated trade-offs. 
Genomics has the potential to shine a light on these discoveries to elucidate the timing and exact nature of these 
hybridisation events. An exemplary study on the plant pathogenic fungus Zymoseptoria pseudotritici 
(Stukenbrock et al., 2012) used the nuclear genomes of five individuals to investigate a recent hybridization event. 
This species shows an unusual pattern of genome-wide diversity, with the genome broken up into small (5.8kb) 
stretches of very high haplotype diversity interspersed between equally long sections showing no differentiation 
within the population. This mosaic pattern of haplotypes is indicative of a recent hybridization event followed by 
a population bottleneck. Estimates of recombination rate and mutation rate in this species allowed two different, 
approximately congruent estimates of the timing of this hybridization event, from data on the size of the haplotype 
blocks and the number of point mutations occurring in the genome.  It is important to note that both understanding 
the pattern of hybridisation, and dating the founding event for these hybrids was only possible through a genome 
level analysis: if only individual genes had been isolated, then the global picture that this study has unearthed 
would have been lost. Through applying these kinds of methods to WGS data from hybrid populations it should 
be possible to gain a more complete picture of the nature and timing of introgression between Schistosoma species. 
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Understanding how often new populations of hybrids are founded, how long they persist and how their population 
genetics differs from parental populations will be important in understanding how these populations are likely to 
respond to MDA and the scope for PZQ resistance to spread within and between populations. 
 
Conclusions 
Accurately parameterised mathematical models incorporating genetic or genomic data can, for example, inform 
on rates of changes of schistosome phenotypes or genotypes associated with drug resistance, so that monitoring 
and evaluation studies can understand what they need to monitor, how and when is best to monitor, and can advise 
on optimal treatment strategies to maximise the gains from limited resources. Although the cost of NGS has fallen 
exponentially in recent years, the outlay of sequencing all 380Mb of the schistosome genome remains currently 
beyond the financial capacity of most institutions, although RAD-seq or exon-capture may represent a more cost-
effective alternative (Gilabert and Wasmuth, 2013). When dealing with a disease that affects the very poorest in 
the world, the most useful public health interventions are those which cost the least and are broadly sustainable; 
therefore it is important that this technology is targeted to answer the most relevant public health questions. These 
NGS technologies, to complement population genetic data available from methodologies such as microsatellites, 
can thus be combined with mathematical models, and we anticipate that the next few years will represent a highly 
exciting and important era in such trans-disciplinary research of profound theoretical and applied importance. 
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